Chemotherapy for head and neck cancer
Between 8% and 61% of patients diagnosed with head and neck cancers have chemotherapy as part of their primary cancer treatment.
Between 8% and 61% of patients diagnosed with head and neck cancers have chemotherapy as part of their primary cancer treatment.
Between 43% and 85% of patients diagnosed with head and neck cancers have radiotherapy as part of their primary cancer treatment.
Treatment for head and neck cancer varies for each cancer type.
Between 32% to 75% of patients diagnosed with head and neck cancers cancer have surgery to remove the tumour as part of their primary cancer treatment.
This trial is looking at less intensive treatment after surgery for oropharyngeal cancer.